Ad is loading...
CRON
Price
$2.10
Change
+$0.05 (+2.44%)
Updated
Nov 22, 03:18 PM (EDT)
102 days until earnings call
LFCR
Price
$7.23
Change
+$0.25 (+3.58%)
Updated
Nov 22, 03:26 PM (EDT)
41 days until earnings call
Ad is loading...

CRON vs LFCR

Header iconCRON vs LFCR Comparison
Open Charts CRON vs LFCRBanner chart's image
Cronos Group
Price$2.10
Change+$0.05 (+2.44%)
Volume$300
CapitalizationN/A
Lifecore Biomedical
Price$7.23
Change+$0.25 (+3.58%)
Volume$375
CapitalizationN/A
CRON vs LFCR Comparison Chart
Loading...
CRON
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
LFCR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CRON vs. LFCR commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRON is a StrongSell and LFCR is a Hold.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (CRON: $2.05 vs. LFCR: $6.98)
Brand notoriety: CRON and LFCR are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CRON: 119% vs. LFCR: 221%
Market capitalization -- CRON: $1B vs. LFCR: $176.87M
CRON [@Pharmaceuticals: Other] is valued at $1B. LFCR’s [@Pharmaceuticals: Other] market capitalization is $176.87M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRON’s FA Score shows that 1 FA rating(s) are green whileLFCR’s FA Score has 1 green FA rating(s).

  • CRON’s FA Score: 1 green, 4 red.
  • LFCR’s FA Score: 1 green, 4 red.
According to our system of comparison, LFCR is a better buy in the long-term than CRON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRON’s TA Score shows that 3 TA indicator(s) are bullish while LFCR’s TA Score has 6 bullish TA indicator(s).

  • CRON’s TA Score: 3 bullish, 6 bearish.
  • LFCR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, LFCR is a better buy in the short-term than CRON.

Price Growth

CRON (@Pharmaceuticals: Other) experienced а -0.97% price change this week, while LFCR (@Pharmaceuticals: Other) price change was +4.49% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.42%. For the same industry, the average monthly price growth was -8.60%, and the average quarterly price growth was -11.11%.

Reported Earning Dates

CRON is expected to report earnings on Mar 04, 2025.

LFCR is expected to report earnings on Jan 02, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.42% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRON($1.01B) has a higher market cap than LFCR($177M). LFCR YTD gains are higher at: 12.763 vs. CRON (-1.914). LFCR has higher annual earnings (EBITDA): -22.64M vs. CRON (-71.8M). CRON has more cash in the bank: 862M vs. LFCR (4.22M). CRON has less debt than LFCR: CRON (2.55M) vs LFCR (157M). LFCR has higher revenues than CRON: LFCR (188M) vs CRON (87.2M).
CRONLFCRCRON / LFCR
Capitalization1.01B177M568%
EBITDA-71.8M-22.64M317%
Gain YTD-1.91412.763-15%
P/E RatioN/AN/A-
Revenue87.2M188M46%
Total Cash862M4.22M20,417%
Total Debt2.55M157M2%
FUNDAMENTALS RATINGS
CRON vs LFCR: Fundamental Ratings
CRON
LFCR
OUTLOOK RATING
1..100
628
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
92
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9098
PRICE GROWTH RATING
1..100
7638
P/E GROWTH RATING
1..100
16
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRON's Valuation (66) in the Pharmaceuticals Other industry is in the same range as LFCR (92) in the Industrial Specialties industry. This means that CRON’s stock grew similarly to LFCR’s over the last 12 months.

CRON's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that CRON’s stock grew similarly to LFCR’s over the last 12 months.

CRON's SMR Rating (90) in the Pharmaceuticals Other industry is in the same range as LFCR (98) in the Industrial Specialties industry. This means that CRON’s stock grew similarly to LFCR’s over the last 12 months.

LFCR's Price Growth Rating (38) in the Industrial Specialties industry is somewhat better than the same rating for CRON (76) in the Pharmaceuticals Other industry. This means that LFCR’s stock grew somewhat faster than CRON’s over the last 12 months.

CRON's P/E Growth Rating (1) in the Pharmaceuticals Other industry is in the same range as LFCR (6) in the Industrial Specialties industry. This means that CRON’s stock grew similarly to LFCR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRONLFCR
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 3 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 5 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 18 days ago
74%
Bullish Trend 3 days ago
74%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 8 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Ad is loading...
CRON
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
LFCR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACLCX8.510.07
+0.83%
American Century Value C
GTAPX14.560.07
+0.48%
Glenmede Quant US Long/Short Equity
VSPGX817.420.80
+0.10%
Vanguard S&P 500 Growth Index Instl
MXSFX9.47N/A
N/A
Empower Real Estate Index Instl
SLAFX28.02-0.30
-1.06%
DWS Latin America Equity S

CRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRON has been closely correlated with SNDL. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRON jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
+1.99%
SNDL - CRON
73%
Closely correlated
+1.02%
TLRY - CRON
72%
Closely correlated
+1.55%
ACB - CRON
67%
Closely correlated
+1.42%
CGC - CRON
67%
Closely correlated
+2.66%
OGI - CRON
64%
Loosely correlated
+2.03%
More

LFCR and

Correlation & Price change

A.I.dvisor tells us that LFCR and SHPH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFCR and SHPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
-6.68%
SHPH - LFCR
31%
Poorly correlated
-1.78%
CRON - LFCR
29%
Poorly correlated
+1.99%
CGC - LFCR
28%
Poorly correlated
+2.66%
TLRY - LFCR
27%
Poorly correlated
+1.55%
OGI - LFCR
26%
Poorly correlated
+2.03%
More